inflammation and immune system pharm

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/40

encourage image

There's no tags or description

Looks like no tags are added yet.

41 Terms

1
New cards

inflammation

response to cellular/tissue injury to phospholipid bilayer, foreign substance, or immune stimulation

2
New cards

early/vascular phase of inflammation

vasodilation, increased permeability of vessels, increased local perfusion, movement of blood substances and fluid from plasma to the injured tissue; up to a week long

3
New cards

delayed/cellular phase of inflammation

accumulation of leukocytes in inflamed tissue, reduced blood flow due to congestion, tissue damage may occur, increased activity of neutrophils, monocytes, lymphocytes; C/S: redness, heat, swelling pain, loss of sensation; lasts hours-days after injury

4
New cards

signs of inflammation

pain, heat, redness, swelling, decreased function

5
New cards

NSAIDs

cyclooxygenase inhibitors

6
New cards

COX-1 enzyme

produces protective/good, "housekeeping" prostaglandins; = PGE2, promotes mucus GI production and inhibits gastric acid secretion; = PGE2 and PG12, vasodilation of renal blood cells promoting perfusion

7
New cards

COX-2 enzyme

produces inflammatory prostaglandins

8
New cards

aspirin

non-selective NSAID (class: salicylates), more COX-2 activity; oldest anti-inflammatory agent; used for analgesia, antipyretic, anti-inflammatory, decreased platelet aggregation (anticoagulant); glucuronyl transferase enzyme needed to metabolize salicylates

9
New cards

phenylbutazone/bute

non-selective NSAID (class: pyrazolone derivatives) for equine pain with musculoskeletal injuries; class: pyrazolone derivatives

10
New cards

carprofen

non-selective NSAID (class: propionic acid derivatives), more COX-2 activity than COX-1; antipyretic, analgesic, anti-inflammatory

11
New cards

ketoprofen/ketofen

non-selective NSAID (class: propionic acid derivatives) for equines; inhibits COX and lipooxygenase

12
New cards

naproxen/equiproxen

non-selective NSAID (class: propionic acid derivatives) for equines

13
New cards

deracoxib/deramaxx

selective COX-2 inhibitor (class: coxib); has anti-cancer effects (transitional cell carcinoma)

14
New cards

firocoxib/previcox/equioxx

selective COX-2 inhibitor (class: coxib); has anti-cancer effects

15
New cards

robenacoxib/onisor

selective COX-2 inhibitor (class: coxib); approved for use in cats

16
New cards

meloxicam

selective COX-2 inhibitor (oxicam group); anti-cancer effects, approved for dogs, cats, large animal; warning of repeated use in cats can lead to acute renal failure and death

17
New cards

piroxicam

selective COX-2 inhibitor (oxicam group); for bladder transitional cell carcinoma & other cancers; not considered safe for routine use

18
New cards

banamine

non-specific COX inhibitor (class: flunixin meglumine); analgesic, antipyretic, anti-inflammatory; for musculoskeletal pain, colic, fever, and inflammation

19
New cards

flunixamine

non-specific COX inhibitor (class: flunixin meglumine); analgesic, antipyretic, anti-inflammatory; for musculoskeletal pain, colic, fever, and inflammation

20
New cards

dicolfenac sodium

non-specific COX inhibitor with possible lipooxygenase inhibition; for topical ophthalmic inflammation

21
New cards

tolfenamic acid

NSAID for pain and inflammation; approved for dogs and cats in Canada and Europe

22
New cards

grapiprant

PGE2 receptor antagonist at EP4 receptors; FDA approved for pain and inflammation from osteoarthritis in dogs; no approved use in cats

23
New cards

dimethyl sulfoxide (DMSO)

NSAID that blocks prostaglandin synthesis and traps free radical hydroxide; topical use for swelling (common ear med) or IV in equines

24
New cards

fuzapladib/panoquell-CA 1

leukocyte function antigen-1 inhibitor (prevents leukocyte adhesion to vascular endothelium and migration); approved for canine pancreatitis; IV SID 3x days

25
New cards

steroid medications

prednisone, prednisolone, dexamethasone, temaril P, hydrocortisone, methylprednisolone sodium succinate (SOLU), methylprednisolone acetate (depo), betamethasone, triamcinolone, fluticasone, budesonide

26
New cards

antihistamine H1 receptor antagonists

chlorpheniramine, diphenhydramine/benadryl, trimeprazine/temaril P, loratadine/claritin, cetirizine/zyrtec

27
New cards

antihistamine H2 receptor antagonists

famotidine/pepcid, ranitidine, cimetidine

28
New cards

immunomodulation

adjustment of immune response to a desired level

29
New cards

immunostimulation

stimulation of the immune system

30
New cards

immunosuppression

suppression of the immune system

31
New cards

induction of immunologic tolerance

decreasing immune response through small amounts of exposure, promoting development of tolerance

32
New cards

cyclosporine

immunosuppressant; suppresses t-cells by blocking calcineurin; NAMES: atomic, neural, gengraf, optimmune, sandimmune

33
New cards

tacrolimus

immunosuppressant; calcenurin inhbitor, blocks t-cell activation; topical for lupus, perianal fistula, KCS

34
New cards

oclacitinib

immunomodulator for atopic dermatitis and pruitis; blocks Janus Kinase enzyme (JAK), mostly JAK 1, causing Il-31 inhibition; cannot be given to young dogs

35
New cards

lokivetmab/cytopoint

monoclonal antibody that binds to nerve IL-31 receptors which blocks Il-31 from binding to its site

36
New cards

bedinvetmab/libela - canine

monoclonal antibody that blocks nerve growth factor, promotes neurogenic inflammation; avoid in pregnant or lactating dogs

37
New cards

frunevetmab/solensia - feline

monoclonal antibody that blocks nerve growth factor, limits release of proinflammatory mediators and lowers neurogenic inflammation

38
New cards

propionibacterium acnes injection

non-specific immunostimulant that induces macrophage activation and lymphokine production, increases natural killer cell activity, enhances cell-mediated immunity

39
New cards

staphylococcus aureus phage lysate (SPL)

immunostimulant that enhances cell-mediated immunity, increases macrophage activity, and stimulates TNF, IL-31, IL-Gamma, & Gamma-interferon production

40
New cards

canine parvovirus monoclonal antibody (CPMA)

monoclonal antibody for canine parvovirus, neutralizes virus before it enters the cell

41
New cards

filgrastim

recombinant human granulocyte colony-stimulating factor that stimulates bone marrow to produce WBCs